Search Results - "Guilmoteau, T"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent by Buisson, A, Nachury, M, Fumery, M, Guilmoteau, T, Leclerc, E, Altwegg, R, Serrero, M, Mathieu, N, Treton, X, Vuitton, L, Pereira, B, Amiot, A, Bouguen, G

    Published in Journal of Crohn's and colitis (21-01-2022)
    “…Abstract Background Several therapeutic options are now available in ulcerative colitis after anti-TNF failure, but no data compared hitherto tofacitinib and…”
    Get full text
    Journal Article
  2. 2

    P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study by Buisson, A, Serrero, M, Altwegg, R, Guilmoteau, T, Bouguen, G, Nachury, M, Amiot, A, Vuitton, L, Treton, X, Caillo, L, Pereira, B, Fumery, M

    Published in Journal of Crohn's and colitis (01-02-2023)
    “…Abstract Background We aimed to compare the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis (UC) previously exposed to at…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Rétinopathie exsudative, calcifications cérébrales dans l’enfance puis cytopénies à l’âge adulte : penser au syndrome de COATS plus by Puel, T., Soavi, C., Guilmoteau, T., Grobost, V., Sabbagh, L., Franceschino, A., Chiambaretta, F., Trouillier, S.

    Published in La revue de medecine interne (01-12-2022)
    “…La maladie de COATS est une rétinopathie exsudative rare, unilatérale, non héréditaire, caractérisée par des télangiectasies et exsudats intra et sous…”
    Get full text
    Journal Article